Moderna said on Friday the European Patent Office had upheld the validity of one of the company's key patents, a win in an ...
Moderna said Friday that the European Patent Office has upheld the validity of one of its key patents, a victory in a ...
The European Patent Office last week upheld one of Moderna’s key patents, handing the biotech an important victory in its ...
Moderna has received its second drug approval from US regulators for an RSV vaccine in older adults, a step forward in the biotech’s efforts to convince investors of its path back to growth after the ...
Moderna Inc (NASDAQ:MRNA) has reportedly achieved a significant victory at the European Patent Office (EPO) in its ongoing ...
USA-based Moderna has won a case at the European Patent Office (EPO) in its dispute with Pfizer and BioNTech over its Covid-19 vaccine, in a boost for the mRNA-vaccine maker in its ongoing legal fight ...
The US District Court of Delaware has ordered AstraZeneca to pay $107.5m to Pfizer in damages for infringing patents related ...
On Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) ...
The US government is nearing an agreement to bankroll a late-stage trial of Moderna’s mRNA pandemic bird flu vaccine, hoping to bolster its pandemic jab stockpile as an H5N1 outbreak spreads through ...
Moderna has won a case at the European Patent Office in its dispute with Pfizer and BioNTech over its COVID-19 vaccine, the ...
Moderna said that the European Patent Office had decided to maintain the validity of one of the company's key patents ...
London: Moderna announced on Friday that it has emerged victorious in a case at the European Patent Office against Pfizer and ...